Tigran Oganesyan Shared a Study on a Novel Oral Device for Oral Mucositis in Cancer Patients
Tigran Oganesyan, Executive Director at OOB Solutions, shared a post on LinkedIn:
“Thrilled to share that our latest research has been published in Supportive Care in Cancer!
The study explores the tolerability and safety of a novel oral device for preventing and treating oral mucositis in patients with hematologic malignancies undergoing chemotherapy. This work reflects a meaningful step toward improving supportive care and patient outcomes in oncology.
Grateful to my senior co-authors Dr Artem Oganesyan and Dr Yervand Hakobyan for their expertise, collaboration, and unwavering commitment to clinical innovation.”
Title: Tolerability and safety of a new oral device for prevention and treatment of oral mucositis in patients with hematologic malignancies undergoing chemotherapy
Authors: Artem Oganesyan, Lusine Harutyunyan, Araksya Vanoyan, Nare Martirosyan, Maria Badikyan, Mark Gregory, Tigran Oganesyan, Nerses Ghahramanyan, Eli D. Ehrenpreis, Yervand Hakobyan
Read the Full Article on Supportive Care in Cancer.
More posts on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023